| Title |
Author |
Type |
Date |
Words |
| Angelina Jolie to have ovaries removed. |
|
|
May 16, 2013 |
117 |
| Hysterectomy does not increase heart disease risk. |
|
|
May 15, 2013 |
303 |
| ASCO 2013: Boehringer Ingelheim to Present Data Across Multiple Cancers, Including Different Treatment Settings for Advanced NSCLC. |
|
|
May 15, 2013 |
2701 |
| Angelina Jolie Avoids Breast and Ovarian Cancer by Having Double Mastectomy [Videos]. |
|
|
May 14, 2013 |
620 |
| Angelina Jolie's Breast Cancer Scare: Actress Underwent Double Mastectomy [PHOTOS]. |
|
|
May 14, 2013 |
639 |
| Vermillion Supports First World Ovarian Cancer Day and Effort to Raise Awareness of the Need for Better Diagnosis and Treatment. |
|
|
May 8, 2013 |
1415 |
| Array Announces Global Phase 3 Trial Evaluating MEK162 In Patients With Low-Grade Serous Ovarian Cancer. |
|
|
May 6, 2013 |
1499 |
| The U.S. Supreme Court Hears Arguments Challenging Patents on Breast and Ovarian Cancer Genes: ACMG Is Plaintiff. |
|
|
Apr 17, 2013 |
771 |
| ASKTHEEXPERTS. |
|
|
Apr 15, 2013 |
274 |
| Artificial ovary replaces missing sex hormones. |
|
|
Apr 7, 2013 |
171 |
| Functional ovaries developed in lab. |
|
|
Mar 27, 2013 |
357 |
| BREASTVEST GOES BLUE FOR OVARIAN CANCER CHARITY. |
|
|
Mar 21, 2013 |
268 |
| Knowing the signs could save your life; The ovarian cancer symptoms that every woman should recognise... |
|
|
Mar 19, 2013 |
649 |
| EGEN, Inc. Announces a Phase I Clinical Trial for Advanced Ovarian Cancer. |
|
|
Mar 19, 2013 |
754 |
| HELPED ME HAVE A bAby; 'I felt new life flowing into my ovaries'. |
|
|
Mar 17, 2013 |
406 |
| Night shifts 'raise ovarian cancer risk'. |
|
|
Mar 15, 2013 |
350 |
| Ovarian cancer warning. |
|
|
Mar 13, 2013 |
168 |
| How dare they put a price on a life when drug would give me valuable extra time? Cancer patient Sharon's fury as experts refuse to fund Avastin. |
|
|
Mar 12, 2013 |
744 |
| Origin of aggressive ovarian cancer identified. |
|
|
Mar 7, 2013 |
551 |
| I always had a tiny sliver of hope..and it gave me a miracle; MUM'S DELIGHT AS SHE BEATS CANCER TO HAVE HER BOY; NEWS SPECIAL. |
|
|
Mar 3, 2013 |
1226 |
| DiaTech Oncology's MiCK Assay Improves Outcomes for Ovarian Cancer Patients. |
|
|
Feb 25, 2013 |
732 |
| I'd fall asleep hoping I wouldn't wake up. |
|
|
Feb 21, 2013 |
535 |
| My illness was a double blow.. learning I was infertile and I had cancer; Two women who survived an ovarian tumour but were robbed of the chance of a baby tell their stories. |
|
|
Feb 21, 2013 |
669 |
| 'I used to ask why me? Now I know it's to help others' OVARIAN CANCER SUFFERER UNA RAISES PROFILE OF DEADLY DISEASE. |
|
|
Feb 17, 2013 |
1020 |
| New drug for low-grade ovarian cancer identified. |
|
|
Feb 15, 2013 |
285 |
| How ovaries are formed in female fetuses. |
|
|
Feb 12, 2013 |
221 |
| Updated test spots more cancers: gene-based Pap smear finds ovarian, uterine malignancies. |
Seppa, Nathan |
|
Feb 9, 2013 |
408 |
| Drug successfully treats low-grade ovarian cancer. |
|
|
Feb 9, 2013 |
462 |
| Urban Land Institute's New York District Council (ULI New York) and Royal Institution of Chartered Surveyors (RIGS) hosted a two-part program entitled "Public Private Partnerships: A Global Perspective," at Allen & Ovary LLP. |
|
|
Feb 6, 2013 |
118 |
| Verastem Initiates Phase 1/1b Clinical Trial of VS-6063 Plus Paclitaxel for Patients with Ovarian Cancer. |
|
|
Feb 5, 2013 |
998 |
| Acceleron Announces the Initiation of Phase 2 Clinical Trial of Dalantercept (ACE-041) in Patients with Ovarian Cancer. |
|
|
Feb 5, 2013 |
860 |
| Cell Therapeutics Announces Data Safety and Monitoring Board Recommendation to Continue the GOG-0212 Phase 3 Clinical Trial of OPAXIOTM as Maintenance Therapy in Ovarian Cancer. |
|
|
Jan 31, 2013 |
1278 |
| My cancer taught me these lessons; views of the North. |
|
Disease/Disorder overview |
Jan 31, 2013 |
260 |
| Ovarian cancer couldn't stop me having a family; How Lorna beat killer disease before getting pregnant. |
|
|
Jan 23, 2013 |
763 |
| Quest PharmaTech Enrolls 40th Patient in its Phase II Oregovomab Front-Line Chemo-Immunotherapy Clinical Trial for Ovarian Cancer in Italy and the U.S. |
|
|
Jan 22, 2013 |
724 |
| Research and Markets: Ovarian Cancer Global Clinical Trials Review, H2, 2012 Profiles Players such as Amgen Inc. and Abbott Laboratories. |
|
|
Jan 21, 2013 |
398 |
| VG Life Sciences Expands Ovarian Cancer Trial; Approved to Study Treatment of Breast, Colon, Lung, Liver and Pancreas Cancer. |
|
|
Jan 14, 2013 |
995 |
| Breastfeeding 'may reduce mums' ovarian cancer risk by two-thirds'. |
|
|
Jan 13, 2013 |
304 |
| CRLX101 Advances to Second Stage of Phase 2 Clinical Trial in Advanced Ovarian Cancer. |
|
|
Jan 7, 2013 |
711 |
| Research and Markets: Ovarian Cancer - Pipeline Review, H2 2012. |
|
|
Jan 2, 2013 |
396 |
| Assessing baccalaureate nursing students' knowledge of ovarian cancer. |
Loerzel, Victoria Wochna |
Report |
Jan 1, 2013 |
1344 |
| The Ovarian Cancer Drug Market Will More Than Triple Over the Next Decade, Increasing from $460 Million in 2011 to $1.4 Billion in 2021. |
|
|
Dec 10, 2012 |
752 |
| VG Life Sciences Provides Additional Insight into Clinical Trial. |
|
|
Dec 6, 2012 |
2489 |
| Common diabetes drug may treat ovarian cancer. |
|
Clinical report |
Dec 6, 2012 |
300 |
| Common diabetes drug improves survival of ovarian cancer patients. |
|
|
Dec 4, 2012 |
350 |
| Detection of Wolbachia endobacteria in Culex quinquefasciatus by Gimenez staining and confirmation by PCR. |
Muniaraj, M.; Paramasivan, R.; Sunish, I.P.; Arunachalam, N.; Mariappan, T.; Leo, S. Victor Jerald; |
|
Dec 1, 2012 |
2208 |
| Merck and Endocyte Announce Acceptance for Review of European Marketing Authorization Applications for Vintafolide and Companion Diagnostic Etarfolatide for Folate-Receptor Positive Platinum-Resistant Ovarian Cancer. |
|
|
Nov 27, 2012 |
1558 |
| Drinking tea can cut ovarian cancer risk. |
|
|
Nov 24, 2012 |
163 |
| Cushman & Wakefield's Future Leaders (CWFL) Group held its first annual Bowl-A-Thon for the Fairfield and Westchester County real estate industry and raised $25,000 for Ovarian Cancer Research Fund. |
|
|
Nov 21, 2012 |
245 |
| Annai Systems And ThoughtWorks Develop Evidence Engine For The Clearity Foundation To Individualize Options For Treatment Of Ovarian Cancer. |
|
|
Nov 15, 2012 |
917 |
| Research and Markets: Global Ovarian Cancer Epidemiology and Patient Flow Analysis - 2012. |
|
|
Nov 15, 2012 |
276 |
| Annai Systems And Thoughtworks Develop Evidence Engine For The Clearity Foundation To Individualize Options For Treatment Of Ovarian Cancer. |
|
|
Nov 15, 2012 |
924 |
| Roche launches additional test for improved management of epithelial ovarian cancer patients. |
|
|
Nov 12, 2012 |
734 |
| New Study Supports Potential Utility of ChemoFx in Primary Ovarian Cancer. |
|
|
Nov 12, 2012 |
485 |
| Aeterna Zentaris Presents Proof-of-Concept for Disorazol Z Cytotoxic Conjugates, such as AEZS-125, in Ovarian Cancer Mouse Model at ENA Symposium. |
|
|
Nov 8, 2012 |
810 |
| Switzerland : Roche medicine Avastin receives EU approval for the treatment of women with recurrent, platinum-sensitive ovarian cancer. |
|
|
Nov 2, 2012 |
211 |
| Aeterna Zentaris to Present Proof of Concept for Disorazol Z Cytotoxic Conjugates such as AEZS-125 in Ovarian Cancer Mouse Model at Upcoming ENA Symposium. |
|
|
Nov 1, 2012 |
502 |
| RayBiotech, Inc. and Abeome Corporation Announce an Agreement Related to Novel Research Products for Ovarian Cancer. |
|
|
Nov 1, 2012 |
588 |
| Azaya Therapeutics Initiates Bioequivalency Study for Regulatory Approval of ATI-0918, a Liposomal Formulation of Doxorubicin Hydrochloride. |
|
Report |
Oct 24, 2012 |
466 |
| VentiRx Pharmaceuticals Initiates Randomized, Placebo-controlled, Phase 2 Trial of VTX-2337 in Patients with Recurrent or Persistent Ovarian Cancer. |
|
|
Oct 22, 2012 |
740 |
| Charity cyclists drop in to raise awareness of ovarian cancer. |
|
|
Oct 17, 2012 |
464 |
| Research and Markets: Chinese Markets for Ovarian Cancer Treatment Drugs Features Companies such as Zhuhai Union Pharmaceutical Co., Ltd and Beijing SL Pharmaceutical Co., Ltd. |
|
|
Oct 11, 2012 |
281 |
| Regular aspirin use can slash risk of serious ovarian cancer. |
|
|
Oct 10, 2012 |
358 |
| Japan : Anti-Cancer Agent AvastinA, Application for Approval of Additional Indication of Ovarian Cancer. |
|
|
Oct 6, 2012 |
381 |
| Local OB/GYN Raises Money for Ovarian Cancer Research. |
|
|
Oct 3, 2012 |
445 |
| Low ovarian cancer risk? Skip screening. |
Splete, Heidi |
|
Oct 1, 2012 |
467 |
| Family history, symptoms key. |
|
Report |
Oct 1, 2012 |
284 |
| Drugs for ovarian tumors may benefit people with deadly breast cancer. |
|
|
Sep 24, 2012 |
640 |
| Breast Cancer Genetic Atlas Finds Similarities To Ovarian Cancer. |
|
|
Sep 24, 2012 |
673 |
| Study reveals genomic similarities between breast cancer and ovarian cancers. |
|
Brief article |
Sep 24, 2012 |
124 |
| Ovarian cancer detection made easy with simple symptom survey. |
|
|
Sep 22, 2012 |
674 |
| Switzerland : Roche's Avastin receives positive opinion from EU authority for the treatment of women with recurrent, platinum-sensitive ovarian cancer. |
|
|
Sep 22, 2012 |
424 |
| Research and Markets: Global Ovarian Cancer Drug Pipeline Capsule - 2012 Update Covers Active Ovarian Cancer Pipeline Molecules in Various Stages of Clinical Trials, Preclinical Research and Drug Discovery. |
|
|
Sep 17, 2012 |
287 |
| Dana-Farber Cancer Institute's Ursula A. Matulonis, MD Article on EntreMed's ENMD-2076 Published in the European Journal of Cancer. |
|
Clinical report |
Sep 6, 2012 |
1336 |
| Research and Markets: Global Ovarian Cancer Drugs Market 2011-2015: Patent Expiration of Key Drugs Could Pose a Challenge to the Growth of This Market. |
|
|
Sep 4, 2012 |
364 |
| Esperance Pharmaceuticals Announces Completion of Run-in Enrollment of Phase 2 Study of EP-100 Plus Paclitaxel in Advanced Ovarian Cancer. |
|
|
Aug 28, 2012 |
582 |
| Cancer Survivor and Texas Olive Orchard Entrepreneur Shares the Bounty with Women Battling Ovarian Cancer. |
|
|
Aug 27, 2012 |
857 |
| Scientists find new ovarian cancer gene. |
|
|
Aug 10, 2012 |
464 |
| Researchers Discover All-Natural Weapon In The War Against Ovarian Cancer. |
|
Clinical report |
Aug 2, 2012 |
551 |
| Cerulean Announces First Patient Dosed in Phase 2 Study of CRLX101 in Ovarian Cancer. |
|
|
Jul 23, 2012 |
588 |
| QVC Creates National Awareness For Charitable Cause. |
|
|
Jul 19, 2012 |
944 |
| Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline. |
|
|
Jul 17, 2012 |
4333 |
| ImmunoGen, Inc. Initiates Phase I Trial of IMGN853 in Ovarian Cancer and Other Solid Tumors Over-Expressing Its Folate Receptor Target. |
|
|
Jul 11, 2012 |
838 |
| Research and Markets: Farletuzumab (Ovarian Cancer) - Analysis and Forecasts to 2020. |
|
Report |
Jul 10, 2012 |
430 |
| Research and Markets: Avastin (Ovarian Cancer) - Analysis and Forecasts to 2020. |
|
Report |
Jul 9, 2012 |
433 |
| Research and Markets: Cisplatin (Ovarian Cancer) - Analysis and Forecasts to 2020. |
|
|
Jul 6, 2012 |
385 |
| Three combined factors found to predict adnexal torsion. |
McNamara, Damian |
|
Jul 1, 2012 |
350 |
| Quinary debulking for epithelial ovarian cancer. |
Edwards, James M.; Lowery, William Jeffrey; Secord, Angeles Alvarez |
Case study |
Jul 1, 2012 |
1392 |
| Femoral metastases from ovarian serous/endometroid adenocarcinoma. |
Beresford-Cleary, N.J.A.; Mehdi, S.A.; Magowan, B. |
Case study |
Jul 1, 2012 |
1142 |
| Research and Markets: Recentin (Ovarian Cancer) - Analysis And Forecasts to 2020. |
|
|
Jun 28, 2012 |
381 |
| Over 300 Participants Gather in Wellesley, MA for W.A.R. Against Ovarian Cancer. |
|
|
Jun 27, 2012 |
452 |
| Caris Life Sciences Launches Caris Target Now(TM) Select for NSCLC, Melanoma, and Cancers of the Breast, Colon, and Ovary. |
|
|
Jun 26, 2012 |
989 |
| Fourth Annual Tea for Teal Event to Honor Ovarian Cancer Crusaders; Late Founder. |
|
|
Jun 21, 2012 |
417 |
| Early Detection Of Ovarian Cancer Gets Substantial Support From Science Investor, Jeffrey Epstein. |
|
|
Jun 20, 2012 |
588 |
| Research and Markets: Hycamtin (Ovarian Cancer) - Analysis and Forecasts to 2020. |
|
Report |
Jun 18, 2012 |
418 |
| Gold Standard Diagnostics Announces Next Generation HE4 Ovarian Cancer Biomarker Testing Solutions. |
|
|
Jun 13, 2012 |
527 |
| I hope our story saves others; It's no wonder that ovarian cancer is described as 'the silent killer' as it's often diagnosed when it's too late. Margaret Smith knows this only too well after losing her only child Kelly to the disease last year. She tells KAREN WILSON her story. |
|
|
Jun 12, 2012 |
1207 |
| ChemoFx[R] Provides Tumor-Specific Information That May Assist in Personalized Chemotherapy Selection. |
|
Clinical report |
Jun 4, 2012 |
507 |
| Genentech Study Showed That Adding Avastin to Chemotherapy Cut the Risk of the Disease Getting Worse in Difficult-to-Treat Recurrent Ovarian Cancer by Half. |
|
|
Jun 2, 2012 |
2405 |
| Who Was Martin Short's Wife, Nancy Dolman, Subject Of Kathie Lee Gifford Gaffe? [VIDEO]. |
|
|
Jun 1, 2012 |
504 |
| Routine sigmoidoscopy cut colorectal cancer. |
Brunk, Doug |
|
Jun 1, 2012 |
627 |
| Simple scoring system could predict adnexal torsion. |
McNamara, Damian |
|
Jun 1, 2012 |
533 |
| Viral Genetics' P-IND Clears FDA To Commence Clinical Trials in Humans. |
|
|
May 21, 2012 |
1661 |
| Research and Markets: Gemzar (Ovarian Cancer) - Analysis and Forecasts to 2020. |
|
Report |
May 18, 2012 |
422 |
| Esperance Pharmaceuticals Initiates Phase 2 Clinical Trial of its Novel Membrane-disrupting Agent, EP-100, in Patients with Advanced Ovarian Cancer. |
|
|
May 17, 2012 |
841 |
| Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012. |
|
|
May 16, 2012 |
3837 |
| Research and Markets: Opaxio (Ovarian Cancer) - Analysis and Forecasts to 2020. |
|
|
May 11, 2012 |
315 |
| RedCannon Security, Inc. and Ovarian Cancer Research Fund (OCRF) launch "Support Ovarian Cancer Research, Prevent Application Downtime" 90-day fundraiser campaign !! |
|
|
May 9, 2012 |
900 |
| Rexahn Pharmaceuticals Submits Archexin Phase II Protocol for Ovarian Cancer to FDA. |
|
Clinical report |
May 8, 2012 |
726 |
| Study fine-tunes endometriosis, ovarian Ca link. |
Schonfeld, Amy Rothman |
Report |
May 1, 2012 |
691 |
| Antiproliferation effect of rosemary (Rosmarinus officinalis) on human ovarian cancer cells in vitro. |
Tai, Joseph; Cheung, Susan; Wu, Matthew; Hasman, David |
Report |
May 1, 2012 |
5199 |
| Mechanism found for DIM in reducing ovarian cancer cell growth. |
Dye, D. |
Brief article |
May 1, 2012 |
178 |
| Rational care or rationing care? Updates and controversies in women's prevention. |
Davisson, Laura |
Report |
May 1, 2012 |
4599 |
| Research and Markets: Ovarian Cancer Global Clinical Trials Review, H2, 2011. |
|
|
Apr 18, 2012 |
344 |
| Vermillion Receives Notice of Allowance for Patent of Biomarker for Ovarian Cancer. |
|
|
Apr 16, 2012 |
865 |
| Taller women more prone to ovarian cancer. |
|
|
Apr 4, 2012 |
442 |
| War on cancer. |
Moss, Ralph |
|
Apr 1, 2012 |
2170 |
| Importance of meta-analyses for evaluating carcinogens. |
Kogevinas, Manolis; Pearce, Neil |
|
Apr 1, 2012 |
857 |
| NAFLD common in teenage girls with PCOS. |
Otto, Alexander M. |
|
Apr 1, 2012 |
499 |
| Effects of decabrominated diphenyl ether (PBDE-209) in regulation of growth and apoptosis of breast, ovarian, and cervical cancer cells. |
Li, Zhi-Hua; Liu, Xiao-Yan; Wang, Na; Chen, Jing-Si; Chen, Yan-Hong; Huang, Jin-Tao; Su, Chun-Hong; |
Report |
Apr 1, 2012 |
5030 |
| Researchers transform cells from woman's ovaries into eggs which may treat infertility. |
|
|
Apr 1, 2012 |
323 |
| Vermillion Receives Notice of Allowance for Patent on Methods for Diagnosing Ovarian Cancer. |
|
|
Mar 28, 2012 |
811 |
| Morphotek[R], Inc. Announces Completion of Enrollment in the FAR-131 Trial for Relapsed Ovarian Cancer. |
|
Clinical report |
Mar 27, 2012 |
672 |
| MabCure Announces Agreement with the City University of New York Center for Advanced Technology to Validate and Evaluate Its Monoclonal Antibodies as Ovarian Cancer Diagnostic Reagents. |
|
|
Mar 19, 2012 |
561 |
| Research and Markets: Ovarian Cancer Partnering 2007-2012 - In-depth Understanding of Ovarian Cancer Deal Trends since 2007. |
|
|
Mar 7, 2012 |
349 |
| Call to end ignorance on cancer. |
|
|
Mar 7, 2012 |
150 |
| Research and Markets: Today 212 Companies Plus Partners Are Developing 286 Drugs Targeting Ovarian Cancer Says 2012 Report. |
|
|
Feb 28, 2012 |
413 |
| National Foundation for Cancer Research Funds Novel Approach to Early Detection of Ovarian Cancer. |
|
|
Feb 23, 2012 |
665 |
| Key to understand biology and treatment of ovarian cancer identified. |
|
Disease/Disorder overview |
Feb 22, 2012 |
611 |
| Time for vintage tea party. |
|
|
Feb 16, 2012 |
295 |
| Researchers take a new look at ovarian cancer treatment. |
|
|
Jan 18, 2012 |
399 |
| WCMC-Q researchers make cancer breakthrough. |
|
|
Jan 17, 2012 |
445 |
| Faulty proteins may be behind ovarian cancer recurrence. |
|
|
Jan 16, 2012 |
399 |
| Tumor-Freezing Treatment Gives Ovarian Cancer Patients Extra Time: Presented at ISET 2012. |
|
|
Jan 15, 2012 |
413 |
| Avastin delays ovarian cancer progression. |
|
|
Dec 29, 2011 |
370 |
| MabCure, Inc. Announces Completion of Its Ovarian Cancer Diagnostic Study in Thailand. |
|
Clinical report |
Dec 15, 2011 |
621 |
| Tiny genetic variation can predict outcome of ovarian cancer treatment. |
|
Clinical report |
Dec 5, 2011 |
398 |
| Townsend's New York observer: phytochemicals and ovarian cancer: preventive, therapeutic, and synergistic benefits. |
Cohen, Marcus A. |
Column |
Dec 1, 2011 |
1902 |
| Potential breakthrough in treating late-stage ovarian cancer. |
|
|
Nov 17, 2011 |
288 |
| Research and Markets: Paclitaxel (Ovarian Cancer) - Analysis and Forecasts to 2020. |
|
|
Nov 16, 2011 |
468 |
| In 2020, the Angiogenesis Inhibitor Drug Class Will Account for Nearly Half of the Ovarian Cancer Drug Market. |
|
|
Nov 15, 2011 |
764 |
| NKTR-102 Demonstrates Synergistic Anti-Tumor Activity in Combination with Pegylated Liposomal Doxorubicin in Platinum-Resistant Ovarian Cancer. |
|
|
Nov 15, 2011 |
1716 |
| Research and Markets: Clinical Trial Recruitment in Orphan Diseases - Patient Numbers in Ovarian Cancer Trials Exceed Other Orphan Diseases in Oncology. |
|
|
Nov 14, 2011 |
400 |
| Common diabetes pill can cut risk of ovarian cancer by 40 pc. |
|
|
Nov 13, 2011 |
393 |
| Research and Markets: Yondelis (Ovarian Cancer) - Analysis and Forecasts to 2020 Contains Detailed Sales Forecasts for 2009-2020 for Yondelis in EU. |
|
|
Nov 2, 2011 |
355 |
| The US cancer program and specific types of cancer, 1975-2007: a failure: Part 3. |
Apostolides, Anthony D.; Apostolides, Ipatia K. |
|
Nov 1, 2011 |
4284 |
| Hysterectomy no boon in early-stage ovarian ca. |
Wendling, Patrice |
|
Nov 1, 2011 |
561 |
| New UK guidelines on recognition and management of ovarian cancer. |
|
Report |
Nov 1, 2011 |
391 |
| Ovarian cancer feeds on fat cells in abdomen. |
|
|
Oct 31, 2011 |
395 |
| TAKING the Pill for 10 [...]. |
|
|
Oct 31, 2011 |
224 |
| IVF doubles women's risk of ovarian cancer 15 years later. |
|
|
Oct 27, 2011 |
271 |
| Contraceptive pill nearly halves women's ovarian cancer risk. |
|
|
Oct 27, 2011 |
282 |
| Research shows Pill use could reduce risk of ovarian cancer; 'THE BENEFITS ARE BALANCED BY A RISK OF BREAST CANCER'. |
|
|
Oct 26, 2011 |
687 |
| New cancer research to be handled with care. |
|
|
Oct 26, 2011 |
219 |
| ReportsnReports - Ovarian Cancer & Breast Cancer Drugs Market Analysis & Forecasts. |
|
|
Oct 20, 2011 |
673 |
| Superior Petroleum Company Helps Sponsor "Teal Ribbon Comedy" Starring Billy Gardell of the CBS Hit Show "Mike and Molly" an Ovarian Cancer Research Benefit, With Support Through the BP Fueling Communities Program. |
|
|
Oct 13, 2011 |
639 |
| Get the facts on ovarian cancer; don't let it be a silent killer. |
|
|
Oct 3, 2011 |
759 |
| deCODE Genetics, in Collaboration with Academic Colleagues and Illumina, Discovers Mutations Conferring High Risk of Ovarian Cancer. |
|
|
Oct 2, 2011 |
805 |
| Special delivery: an obstetrician who thanks the 'sailing fertility gods' for the birth of his son is racing to Hobart to raise awareness for ovarian cancer research. |
|
|
Oct 1, 2011 |
446 |
| Genetic and molecular studies in ovarian cancer patients. |
Sowjanya, B. Lakshmi; Devi, P.K. Rudrama |
Report |
Oct 1, 2011 |
433 |
| Research and Markets: Disease and Therapy Review: Ovarian Cancer 2011 - Incidence, Prevalence and Mortality and %s for Major Countries Worldwide. |
|
|
Sep 29, 2011 |
352 |
| Research and Markets: Global Ovarian Cancer Drug Pipeline Capsule - 2011 Report Will Help Executives to Keep A Track of Their Competitors and Understand Their Pipeline Molecules. |
|
|
Sep 27, 2011 |
404 |
| 1st recurrent gene fusion in ovarian cancer identified. |
|
|
Sep 21, 2011 |
277 |
| Kathy Bates, The Ovarian Cancer National Alliance and RESOLVE Join Mediaplanet and Key Industry Leaders in Campaign to Educate the Public on Ovarian Cancer and Reproductive Health Issues. |
|
|
Sep 16, 2011 |
573 |
| New 'Trojan Horse' strategy to fight ovarian cancer developed. |
|
|
Sep 15, 2011 |
343 |
| DavidBartonGym Launches Second Annual National Initiative to Raise Funds to Help Women With Ovarian Cancer. |
|
|
Sep 12, 2011 |
790 |
| Asian Activities Report for September 9, 2011: HealthLinx Limited (ASX:HTX) to Commence Ovarian Cancer Diagnostic Study in China. |
|
|
Sep 9, 2011 |
305 |
| FirstRain Raises More Than $30,000 for Ovarian Cancer Research Fund in Maui Ocean Swim. |
|
|
Sep 7, 2011 |
712 |
| September Is Ovarian Cancer Awareness Month: Cancer Specialist Reveals What Every Woman Needs to Know. |
|
|
Sep 2, 2011 |
441 |
| Ovarian cancer and asbestos exposure. |
|
Brief article |
Sep 1, 2011 |
146 |
| Occupational exposure to asbestos and ovarian cancer: a meta-analysis. |
Camargo, M. Constanza; Stayner, Leslie T.; Straif, Kurt; Reina, Margarita; Al-Alem, Umaima; Demers, |
Report |
Sep 1, 2011 |
8235 |
| Salpingectomy in ovarian Ca prevention on trial. |
Susan |
|
Sep 1, 2011 |
1102 |
| Data needed on salpingectomy to prevent cancer: expert analysis from the annual meeting of the society of obstetricians and gynaecologists of Canada. |
Susan |
|
Sep 1, 2011 |
1008 |
| Turn The Towns Teal, Inc.[R] and Frederick Wildman and Sons, Ltd. Together Again in the Crusade for Ovarian Cancer Awareness. |
|
|
Aug 30, 2011 |
5930 |
| Tropical plant extracts offer new hope for effective ovarian cancer therapy. |
|
|
Aug 26, 2011 |
242 |
| A BLOOD molecule has been [...]. |
|
|
Aug 22, 2011 |
225 |
| OVARIAN CANCER SCREENING HOPE. |
|
|
Aug 17, 2011 |
212 |
| Ovarian cancer discovery hope; BRITAIN TODAY HEALTH. |
|
|
Aug 17, 2011 |
116 |
| Biomarker that could help spot early signs of ovarian cancer discovered. |
|
|
Aug 17, 2011 |
270 |
| Gene linked to ovarian cancer risk. |
|
|
Aug 9, 2011 |
255 |
| Engineered human T cells hit "Achilles' Heel" of ovarian cancer cells. |
|
|
Aug 9, 2011 |
289 |
| Simple ovarian cancer test to be available in 2-yrs after faulty gene discovery. |
|
|
Aug 8, 2011 |
181 |
| Gene linked to ovarian cancer risk. |
|
|
Aug 7, 2011 |
255 |
| ImmunoCellular Therapeutics Issued New Patent for Diagnosis and Treatment of Ovarian Cancer and Multiple Myeloma. |
|
|
Aug 3, 2011 |
400 |
| CytRx's INNO-206 in Combination Therapy Induces Complete Remissions in Aggressively Growing Ovarian Cancer Tumor Model. |
|
|
Aug 1, 2011 |
1309 |
| Screening method does not reduce ovarian cancer mortality. |
McBride, Deborah |
Brief article |
Aug 1, 2011 |
263 |
| Ovarian strumal carcinoid presenting as severe progressive constipation. |
Kachhawa, G.; Kumar, S.; Singh, G.; Mathur, S.; Kumar, L.; Sharma, J. |
Case study |
Aug 1, 2011 |
1451 |
| NCCN and Experts from China Collaborate to Develop Colon, Kidney, Non-Small Cell Lung, and Ovarian Cancer Guidelines, China Editions. |
|
|
Jul 27, 2011 |
750 |
| Making A Difference With Designer Deals. |
|
Company overview |
Jul 27, 2011 |
802 |
| Marshall Edwards Announces Publication of Pre-Clinical Study Showing Activity in Chemotherapy-Resistant Ovarian Cancer Stem Cells. |
|
Report |
Jul 27, 2011 |
851 |
| VaxOnco to Sponsor Phase I Trial of a Folate Receptor Alpha-targeted Breast/Ovarian Cancer Therapeutic Vaccine That Recently Received Investigational New Drug Approval From FDA. |
|
|
Jul 25, 2011 |
400 |
| How cancer stem cells recruit normal stem cells to fuel ovarian cancer. |
|
|
Jul 19, 2011 |
362 |
| Ovarian cancer campaign to raise awareness. |
|
|
Jul 4, 2011 |
387 |
| THE lives of 500 women [...]. |
|
|
Jul 4, 2011 |
270 |
| Almac data to be presented at annual ASCO meeting. |
|
|
Jul 1, 2011 |
664 |
| Detailed genomic analysis of ovarian cancer may lead to effective treatment. |
|
|
Jun 30, 2011 |
282 |
| The Cancer Genome Atlas completes detailed ovarian cancer analysis. |
|
|
Jun 29, 2011 |
119 |
| Call for earlier cancer diagnosis. |
|
|
Jun 27, 2011 |
243 |
| Turn The Towns Teal[R] Launches National Campaign to Raise Awareness of Ovarian Cancer. |
|
|
Jun 13, 2011 |
414 |
| Hope for ovarian cancer sufferers; Faulty gene could hold key to which drugs will prove most effective. |
|
|
Jun 7, 2011 |
492 |
| Sufferers of ovarian cancer get new hope; Tyneside scientists make breakthrough with rogue gene. |
|
|
Jun 7, 2011 |
578 |
| New Publication Validates Use of HE4 in Evaluating Risk of Ovarian Cancer. |
|
|
Jun 6, 2011 |
996 |
| New Publication Validates Use of HE4 in Evaluating Risk of Ovarian Cancer. |
|
|
Jun 6, 2011 |
1010 |
| Genentech Announces Data to Show Avastin-Based Regimen Halved the Risk of Disease Getting Worse in Women with Recurrent Ovarian Cancer. |
|
|
Jun 4, 2011 |
2285 |
| Exelixis' Cabozantinib Demonstrates Encouraging Clinical Activity in Patients with Metastatic Ovarian Cancer. |
|
|
Jun 4, 2011 |
1659 |
| EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients. |
|
|
Jun 3, 2011 |
1108 |
| PARP inhibitor delays progression in ovarian ca. |
Wachter, Kerri |
|
Jun 1, 2011 |
583 |
| Night sweats. |
Ishida, Yasuo |
|
Jun 1, 2011 |
173 |
| Almac Data to Be Presented at Annual ASCO Meeting. |
|
|
May 31, 2011 |
793 |
| New insights into treatment of hereditary breast, ovarian cancer. |
|
|
May 28, 2011 |
195 |
| Positive steps in the ovarian cancer fight. |
|
|
May 24, 2011 |
326 |
| OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment. |
|
|
May 24, 2011 |
1087 |
| Genentech to Present Significant Progress in Advanced Skin, Lung and Ovarian Cancers at ASCO. |
|
|
May 18, 2011 |
2498 |
| OVA1 Blood Test Detects Ovarian Cancer More Accurately Than Medically Accepted CA 125 Method for Evaluating Women with Ovarian Mass. |
|
|
May 12, 2011 |
1749 |
| Reducing time to diagnosis of ovarian cancer may not improve outcome. |
|
|
May 4, 2011 |
332 |
| Advanced ovarian cancer often treated suboptimally. |
McNamara, Damian |
|
May 1, 2011 |
888 |
| Wider role for neoadjuvant chemo in ovarian cancer. |
McNamara, Damian |
|
May 1, 2011 |
645 |
| Blood test call over ovarian cancer. |
|
|
Apr 29, 2011 |
238 |
| Blood test call over ovarian cancer. |
|
|
Apr 28, 2011 |
238 |
| Blood test may help fight ovarian cancer. |
|
|
Apr 27, 2011 |
351 |
| Blood test call over ovarian cancer. |
|
|
Apr 27, 2011 |
238 |
| FDA Could Approve Endocyte's EC145 to Treat Ovarian Cancer in Women: Analyst. |
|
|
Apr 25, 2011 |
642 |
| FDA Grants Orphan Drug Designation for Nektar's Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer. |
|
|
Apr 21, 2011 |
1319 |
| ImmunoGen, Inc. Announces First Data for its Novel Therapeutic for Ovarian Cancer and Other Carcinomas. |
|
|
Apr 4, 2011 |
865 |
| The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancers. |
Vesprini, Danny; Narod, Steven A; Trachtenberg, John; Crook, Juanita; Jalali, Farid; Preiner, John; |
Case study |
Apr 1, 2011 |
3938 |
| Advanced ovarian ca often treated suboptimally. |
Mcnamara, Damian |
|
Apr 1, 2011 |
1035 |
| Adiposity magnifies oophorectomy's CV impact: finding may change practice for preventing breast, ovarian cancer in BRCAI and -2 mutation carriers. |
Jancin, Bruce |
|
Apr 1, 2011 |
856 |
| The case of the uncontrolled nausea and vomiting. |
Eisenberg, Seth |
|
Apr 1, 2011 |
308 |
| White Shirt Campaign 2011. |
|
|
Mar 28, 2011 |
895 |
| OVA1 Included in Latest ACOG/SGO Committee Opinion. |
|
|
Mar 14, 2011 |
1017 |
| FIVE-YEAR survival rates among women [...]. |
|
|
Mar 14, 2011 |
207 |
| New Treatment Options Lead to Steady Progress Against Ovarian Cancer; Clinical Trials Remain Imperative. |
|
|
Mar 14, 2011 |
1484 |
| How ovarian cancer resists chemotherapy. |
|
|
Mar 4, 2011 |
281 |
| Spot signs during ovarian cancer month. |
|
|
Mar 3, 2011 |
194 |
| Research and Markets: Ovarian Cancer Global Clinical Trials Review Q4 2010. |
|
|
Mar 2, 2011 |
486 |
| MabCure Inc., Corporate Update. |
|
Clinical report |
Mar 1, 2011 |
1112 |
| Beware the silent killer; SPOTTING OVARIAN CANCER SYMPTOMS CAN BE SO HARD THAT IT OFTEN COMES TOO LATE. |
|
|
Feb 28, 2011 |
573 |
| Australian Market Report of February 24, 2011: Viralytics (ASX:VLA) Receive Chinese Notice To Grant Patent Of Use Of EVATAK(TM) In Ovarian Cancer. |
|
|
Feb 24, 2011 |
437 |
| Australian Market Report of February 21, 2011: Prima BioMed (ASX:PRR) To Commence Clinical Trial For Ovarian Cancer Immunotherapy Vaccine. |
|
|
Feb 21, 2011 |
333 |
| Research and Markets: Pipeline Insight: Cancer Overview - Breast and Gynecological Cancers - Promising Agents Emerge for BRCA Positive Patients. |
|
|
Feb 16, 2011 |
539 |
| Reportlinker Adds Pipeline Insight: Cancer Overview- Breast and Gynecological Cancers - Promising agents emerge for BRCA positive patients. |
|
Disease/Disorder overview |
Feb 15, 2011 |
603 |
| Third Phase III Study of Avastin-Based Regimen Met Primary Endpoint in Ovarian Cancer. |
|
|
Feb 8, 2011 |
2721 |
| Research and Markets: Surgery for Ovarian Cancer: Principles and Practice Second Edition. |
|
|
Feb 4, 2011 |
597 |
| New discovery may help in the fight against ovarian cancer. |
|
|
Feb 4, 2011 |
278 |
| LILLY (ELI) & COMPANY - Necitumumab Trial DMC. |
|
|
Feb 3, 2011 |
2864 |
| FDA Awards EGEN, Inc. Orphan -Drug Grant for Clinical Development of EGEN-001 for Treatment of Ovarian Cancer. |
|
|
Feb 2, 2011 |
619 |
| For the Treatment of Second-Line Platinum Sensitive Advanced Ovarian Cancer, One-Third of Surveyed Oncologists Indicate That Paclitaxel/Carboplatin Has the Best Overall Clinical Profile When Compared to Other Currently Available Therapies. |
|
|
Jan 27, 2011 |
719 |
| Research and Markets: Ovarian Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017. |
|
|
Jan 20, 2011 |
1072 |
| Rational care or rationing care? Updates and controversies in women's prevention. |
Davisson, Laura |
Report |
Jan 1, 2011 |
4054 |
| Vitamin D deficiency in ovarian cancer. |
Murphy, Kathleen |
Report |
Dec 22, 2010 |
555 |
| Electronic nose smells cancer. |
|
|
Dec 21, 2010 |
276 |
| EGEN, Inc. Announces that Phase II Clinical Trial for Advanced Ovarian Cancer is Open for Enrollment. |
|
|
Dec 13, 2010 |
762 |
| For the Treatment of Ovarian Cancer, Pegylated Liposomal Doxorubicin/Carboplatin Will Replace Paclitaxel/Carboplatin as the Standard Second-Line Treatment for Platinum Sensitive Patients. |
|
|
Dec 8, 2010 |
792 |
| Drug-Treatment Opportunities in Advanced Ovarian Cancer Will be Limited by a Reduced Risk of Disease Recurrence and an Only Modest Increase in Incidence. |
|
|
Dec 8, 2010 |
684 |
| CA125 immune complexes in ovarian cancer patients with low CA125 concentrations. |
Cramer, Daniel W.; O'Rourke, Dennis J.; Vitonis, Allison F.; Matulonis, Ursula A.; DiJohnson, Daniel |
|
Dec 1, 2010 |
2437 |
| High density and scale-up cultivation of recombinant Chinese Hamster Ovary cells (CHO) using microcarrier-based stirred bioreactor. |
Nasser, Abdel; El-Moghazy, A. |
|
Dec 1, 2010 |
2130 |
| Cancer drug developer Exelixis Inc (South San Francisco CA) said interim data from two mid-stage trials of an experimental drug showed promise in patients with a type of prostate cancer and ovarian cancer, sending its shares up 31% for the week. |
|
|
Nov 22, 2010 |
471 |
| Exelixis Reports Promising Interim Data From Patients With Ovarian Cancer Treated With XL184. |
|
|
Nov 18, 2010 |
1403 |
| Marshall Edwards Announces Presentation of New Data Showing Activity in Chemotherapy-Resistant Ovarian Cancer Cells. |
|
|
Nov 18, 2010 |
818 |
| That bloated feeling was ovarian cancer; SUFFERER: DON'T IGNORE THE SIGNS. |
|
|
Nov 15, 2010 |
504 |
| Hope for ovarian cancer patients. |
|
|
Nov 8, 2010 |
196 |
| Cell test may aid women; Hopes rise of ovarian cancer breakthrough. |
|
|
Nov 8, 2010 |
431 |
| Synta Announces Gynecologic Oncology Group (GOG) to Initiate Phase 2 Clinical Trial of Elesclomol for the Treatment of Ovarian Cancer. |
|
|
Nov 1, 2010 |
1497 |
| Prophylactic BSO option for high-risk women. |
Wachter, Kerri |
|
Nov 1, 2010 |
846 |
| Journal abstracts: metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner. |
|
Brief article |
Nov 1, 2010 |
250 |
| Genetic variants linked to ovarian cancer discovered. |
|
Brief article |
Nov 1, 2010 |
133 |
| Dr. Fred Ueland, Markey Cancer Center, University of Kentucky Presents OVA1(TM) High Sensitivity Data at the 13th Annual International Gynecologic Cancer Society Meeting. |
|
|
Oct 25, 2010 |
924 |
| Research and Markets: Disease and Therapy Review: Ovarian Cancer - Incidence, Prevalence and Mortality Numbers and Percentages for Major Countries Worldwide. |
|
|
Oct 21, 2010 |
338 |
| Oestrogen therapy 'causes ovarian cancer to grow five times faster'. |
|
|
Oct 21, 2010 |
268 |
| MabCure Signs a Collaboration Agreement with a Leading Medical Center in Europe for a Study Aimed at Further Development of a Blood Test for Ovarian Cancer. |
|
|
Oct 19, 2010 |
886 |
| Ovarian ca risk may warrant prophylactic BSO. |
Wachter, Kerri |
|
Oct 15, 2010 |
759 |
| Drug for ovarian cancer. |
|
|
Oct 12, 2010 |
125 |
| New drug shows promise against platinum resistant ovarian cancer. |
|
Clinical report |
Oct 10, 2010 |
401 |
| Updated AMG 386 Data Demonstrate Promising Antitumor Activity in Patients With Recurrent Ovarian Cancer. |
|
|
Oct 9, 2010 |
1793 |
| Mutations in two genes implicated in ovarian cancer. |
Brunk, Doug |
|
Oct 1, 2010 |
619 |
| Eaton Vance Executive Philanthropic in Fight Against Cancer. |
|
|
Sep 30, 2010 |
947 |
| Ovary removal boosts survival: procedure shown to benefit women with BRCA mutations. |
Seppa, Nathan |
|
Sep 25, 2010 |
396 |
| Guidelines ensure women with ovarian cancer are both diagnosed and treated quickly. |
|
|
Sep 24, 2010 |
410 |
| New genetic links to ovarian cancer risk discovered. |
|
|
Sep 20, 2010 |
611 |
| Commencement of a Phase II Clinical Trial of SG2000 in Ovarian Cancer. |
|
|
Sep 15, 2010 |
899 |
| Prophylaxis improves mortality in BRCA carriers. |
Moon, Mary Ann |
|
Sep 15, 2010 |
518 |
| 'Treasure Your Chest' With Giuliana Rancic. |
|
|
Sep 14, 2010 |
1230 |
| About one in 400 women carry genetic mutations that put them at high risk for breast and ovarian cancer. |
|
|
Sep 13, 2010 |
245 |
| Genes tied to deadliest ovarian cancers identified. |
|
|
Sep 9, 2010 |
296 |
| Kaleidoscope of Hope Foundation Announces Tenth Anniversary Celebration Brunch. |
|
|
Sep 8, 2010 |
689 |
| DavidBartonGym Launches National Training Initiative to Fight Ovarian Cancer and Raise $100,000 in September 2010. |
|
|
Sep 1, 2010 |
679 |
| Colorado Ovarian Cancer Alliance March on the Capitol Sept. 3. |
|
|
Aug 31, 2010 |
414 |
| Kaleidoscope of Hope Foundation Announces 11th Annual Walkathons. |
|
|
Aug 31, 2010 |
616 |
| Research and Markets: Stakeholder Opinions: Ovarian Cancer - Approaching the Era of Molecular Targeted Therapy. |
|
|
Aug 17, 2010 |
414 |
| Potential new target for treatment of ovarian cancer identified. |
|
|
Aug 17, 2010 |
362 |
| Susan G. Komen for the Cure[R] and Ovarian Cancer National Alliance Appeal to FDA and Key Lawmakers on Avastin Issue. |
|
|
Aug 13, 2010 |
894 |
| NEW BLOOD TEST OFFERS HOPE FOR EARLY DETECTION OF OVARIAN CANCER. |
|
|
Aug 9, 2010 |
294 |
| Curis Provides Update on Genentech's Phase II Clinical Trial of GDC-0449 in Advanced Ovarian Cancer Patients. |
|
|
Aug 9, 2010 |
1722 |
| Over 250 corporate real estate professionals and service providers attended SHARE's (Self Help for Women with Breast or Ovarian Cancer) 2nd Annual Design, Construction & Real Estate Reception at Haworth Showroom. |
|
|
Aug 4, 2010 |
165 |
| MabCure, Inc. Files Provisional Patent in the U.S. for Ovarian Cancer Antibodies. |
|
|
Aug 3, 2010 |
798 |
| Power Balance Goes All In For The Cure. |
|
|
Aug 2, 2010 |
676 |
| New strategy screens for ovarian cancer. |
McBride, Deborah |
Brief article |
Aug 1, 2010 |
300 |
| PAX-2 is a helpful marker for diagnosing metastatic renal cell carcinoma: comparison with the renal cell carcinoma marker antigen and kidney-specific cadherin. |
Ozcan, Ayhan; Zhai, Qihui; Javed, Rehana; Shen, Steven S.; Coffey, Donna; Krishnan, Bhuvaneswari; Tr |
|
Aug 1, 2010 |
5492 |
| Giving Back Has Never Been So Fashion Forward! |
|
|
Jul 29, 2010 |
647 |
| A NEW genetic marker has [...]. |
|
|
Jul 26, 2010 |
228 |
